| 摘要: |
| 2019年12月以来，新型冠状病毒肺炎疫情快速全国各地传播，并波及部分国外地区。新型冠状病毒肺炎患者是最主要传染源，人际间传播性强，飞沫传播是最主要传播途径。潜伏期多数在7天内。常见临床表现有发热、呼吸道症状、乏力，外周血淋巴细胞计数正常或减少，胸部影像学检查以两肺外周多发磨玻璃常见。诊断依赖于流行病学史和临床表现，确诊病例需要呼吸道或血液样本新型冠状病毒病毒核酸检测阳性。隔离患者、氧疗和抗病毒治疗是主要治疗措施。激素治疗效果尚不确定。中西医结合治疗有可能是有效的中国特色治疗方法。 |
| 关键词: 新型冠状病毒肺炎 发热 呼吸道症状 淋巴细胞 诊断 |
| DOI： |
| 分类号: |
| 基金项目:广西壮族自治区科学技术厅广西重点研发计划,桂AB16380218；广西壮族自治区卫生健康委员会广西医疗卫生适宜技术研究与开发课题,S201315-05 |
|
| Current diagnosis and management of 2019 novel coronavirus pneumonia |
|
Qin Zhi-qiang, Zhong Xiao-gang
|
|
Department of Pulmonary and Critical Care Medicine, Department of Infectious Disease, Headquarters of nCoV Pneumonia Prevention and Control of the Hospital
|
| Abstract: |
| Since December of 2019, novel coronavirus (nCoV) pneumonia has affected the whole China and some other countries in a short time. The patients with nCoV pneumonia is the most important source of the nCoV, which transmission of person-to-person via droplet infection predominantly. Most the patients' incubation period is within 7 days. Fever, respiratory symptoms, normal or decreased lymphocyte, and bilateral patchy ground-glass opacity of CT findings are the common clinical manifestations. The possible diagnosis of the nCoV pneumonia bases on the epidemiology and clinical findings, but the definite diagnosis needs the positive nCoV by the real-time RT-PCR assay. Isolation of patients, oxygen supplement and anti-virus therapy are the regular measures. The efficacy of corticosteroids is still unconfirmed for this disease. Combination of traditional Chinese medicine and west medicine may be effective management with Chinese characteristics. |
| Key words: novel coronavirus pneumonia fever respiratory symptom lymphocyte diagnosis |
